Citations

Clear

13603 citation(s) found for "_, _".

Letter to the editor concerning the article: ‘The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview’
Ágh, Tamás , Eliasson, Lina , Borah, Bijan J.

Mayo Clinic

British Journal of Clinical Pharmacology | February 26, 2025 | Volume: 91 | Issue: 5 | Pages: 1516-1517

10.1002/bcp.70030 | PMID 39989028 Get It

Research Letter: Rehabilitation Planning Using Rasch Analysis of the Mayo-Portland Adaptability Inventory, 4th Edition
Malec, James F.

Mayo Clinic

Journal of Head Trauma Rehabilitation | February 25, 2025 | Volume: 40 | Issue: 5 | Pages: 387-392

10.1097/htr.0000000000001042 | PMID 39998556 Get It

Objective: To present a method for examining associations among items and total T-score for the Mayo-Portland Adaptability Inventory (4th edition; MPAI-4) that can assist in rehabilitation planning. Setting: Advanced postacute brain injury rehabilitation programs. Method: Description and presentation of a rehabilitation planning guide based on Rasch analysis of the MPAI-4 and application in 2 cases of participants with traumatic brain injury. Results: Initial individualized rehabilitation treatment recommendations derived from examination of the rehabilitation planning guide for specific participants are described. Conclusions: Systematic examination of a visual depiction of associations among MPAI-4 items and total T-score identified through Rasch analysis is useful for rehabilitation planning and in communication and education with participants and families.
The impact of motor, non-motor, and social aspects on the sexual health of women living with Parkinson's disease
Nóbrega, Kátia Cirilo Costa, Nascimento, Isaíra Almeida Pereira da Silva , Souza, Bruno Rafael Antunes , Gonçalves, Raíssa Amorim , Martins, Thalyta Silva, Santos, Geovanna Ferreira, Silva, Bruno Eron de Almeida da, Frazão, André Helene, Savica, Rodolfo , Helene Frazão, André , Roque, Antônio Carlos , Savica, Rodolfo , Pimentel Piemonte, Maria Elisa , Piemonte, Maria Elisa Pimentel

Mayo Clinic

Journal of Parkinson’s Disease | February 25, 2025 | Volume: 15 | Issue: 2 | Pages: 421-433

10.1177/1877718x251315375 | PMID 39995067 Get It

Background Sexual health is influenced by a complex interplay of biological, psychological, and social factors, all of which can be impacted by Parkinson's disease (PD). Female sexual dysfunction includes reduced sexual desire and/or arousal, pain during sexual activity, or difficulty achieving orgasm. Despite its impact on quality of life, sexual health in women with PD remains poorly understood. Objective To investigate the impact of motor, non-motor, and social PD aspects on sexual health of women with PD. Methods We conducted a cross-sectional study with 100 women with PD (Hoehn and Yahr stages 1–3) who reported an active sex life in the last six months. Data were collected via remote interviews and included demographic and clinical features, cognitive capacity, motor and non-motor experiences, fatigue, self-esteem, sleep disorders, couple relationship quality, depressive symptoms, and sexual health assessments using the Female Sexual Function Index (FSFI) and Sexual Quotient-Female (SQ-F). Multiple regression models were used to identify predictors of FSFI and SQ-F scores. Results Results indicated that while several motor, non-motor, and social factors correlated with sexual health, only couple relationship quality and sleep quality significantly predicted both short-term (FSFI) and long-term (SQ-F) sexual health. No significant associations were observed with age, disease onset, postmenopausal status, or daily medication dosage. Conclusions The present study's evidence identifies multiple key areas, such as couple's relationship quality and sleep quality that could be targeted for intervention to improve sexual health in women with PD.
Characterization, commissioning, and clinical evaluation of a commercial BeO optically stimulated luminescence (OSL) system
Kowalski, J., Erickson, Brett G. , Wu, Qiuwen , Li, Xinyi , Yoo, Sua , Kowalski, Joseph P.

Mayo Clinic

Journal of Applied Clinical Medical Physics | February 22, 2025 | Volume: 26 | Issue: 4 | Pages: No page available

10.1002/acm2.70057 | PMID 39985562 Get It

AbstractThis article investigates the performance of a commercial BeO optically stimulated luminescent (OSL) dosimetry system (myOSLchip, RadPro GmbH International, Remscheid, Germany) through the application of the commissioning framework for luminescent dosimeters as described in the American Association of Physicists in Medicine Task Group 191 (AAPM TG191) report. Initial clinical experiences and dosimetric results are also presented. The following properties of the system were characterized: linearity correction factors ranged from ‐0.5% to +3% for dose levels spanning 0.1 to 20 Gy. Beam quality correction factors (relative to 6 MV) ranged from ‐4.5% (2.5FFF) to +4.5% (15MV) for photon beams and +1.9% (6 MeV) to +4.3% (20 MeV) for electron beams. An average (µ) signal loss per reading of ‐2.13% ± 0.20% was measured, however greater signal loss was observed in the first reading (µ = ‐2.6% ± 0.46%). An initial decline in individual element sensitivity relative to baseline was observed from 0–15 Gy cumulative dose (µ = ‐1.98% ± 0.55%), with negligible further deterioration from 15–32 Gy (µ = ‐2.38% ± 0.85%). Post‐irradiation, there was a transient OSL signal which faded with a half‐life of 1.8 min; this signal enhancement was +5% at 5 min post‐irradiation and +1% at 15 min relative to 24 h. Dosimeter response was not dependent on average dose rate in the range of 100–2500 MU/min. With respect to clinical testing, equal or superior performance compared with aluminum oxide OSLs (nanoDots) is shown for a range of clinical techniques and modalities including TSET, TBI, en‐face electrons, and pacemaker/out‐of‐field measurements. The feasibility of myOSLchip to serve as a primary clinical in vivo dosimetry system and direct replacement for Landauer's microStar system is demonstrated.
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Gutmair, Katja , Villa, Diego , Cunningham, Nicholas , Silkenstedt, Elisabeth , Rimsza, Lisa M. , Ramsower, Colleen , Scott, David W. , Dreyling, Martin , Hoster, Eva , Rimsza, Lisa, Gerrie, Alina S , Kluin-Nelemans, Hanneke C , Dreyling, Martin , Hoster, Eva , Scott, David W , Ramsower, Colleen A , Cunningham, Nicholas, Gerrie, Alina S. , Kluin‐Nelemans, Hanneke C.

Mayo Clinic

Blood Advances | February 21, 2025 | Volume: 9 | Issue: 9 | Pages: 2302-2306

10.1182/bloodadvances.2024015292 | PMID 39983085 Get It

Executive Summary of a Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU
Lewis, Kimberley , Balas, Michele C. , Stollings, Joanna L. , McNett, Molly , Girard, Timothy D. , Chanques, Gérald , Weinhouse, Gerald L., Brummel, Nathan E., Duby, Jeremiah J. , Hall-Melnychuk, Erin L., Krupp, Anna , Louzon, Patricia , Tate, Judith A. , Young, Bethany , Jennings, Ron, Hines, Anitra, Ross, Chris, Carayannopoulos, Kallirroi Laiya , Aldrich, Janet , Girard, Timothy D , Kho, Michelle E. , Pandharipande, Pratik , Brummel, Nathan E. , Chlan, Linda L. , Cordoza, Makayla L. , Gélinas, Céline , Ross, Chris, Aldrich, J. Matthew

Mayo Clinic

Critical Care Medicine | February 21, 2025 | Volume: 53 | Issue: 3 | Pages: e701-e710

10.1097/ccm.0000000000006573 | PMID 39982138 Get It

Diagnostic, survival, and tumor control outcomes of parapharyngeal space liposarcoma: a systematic review
Vasudevan, Srivatsa Surya , Kandrikar, Tiba Yamin , Janus, Jeffrey R. , Candelo, Estephanía

Mayo Clinic

Acta Oto-Laryngologica | February 21, 2025 | Volume: 145 | Issue: 4 | Pages: 348-354

10.1080/00016489.2025.2462688 | PMID 39982322 Get It

A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU
Lewis, Kimberley , Balas, Michele C. , Stollings, Joanna L. , McNett, Molly , Girard, Timothy D., Chanques, Gérald , Kho, Michelle E. , Weinhouse, Gerald L., Brummel, Nathan E., Duby, Jeremiah J. , Hall-Melnychuk, Erin L., Krupp, Anna , Louzon, Patricia , Tate, Judith A. , Young, Bethany , Jennings, Ron, Hines, Anitra, Ross, Chris, Carayannopoulos, Kallirroi Laiya , Aldrich, Janet , Girard, Timothy D. , Girard, Timothy D , Pandharipande, Pratik , Brummel, Nathan E. , Chlan, Linda L. , Cordoza, Makayla L. , Gélinas, Céline , Aldrich, J. Matthew

Mayo Clinic

Critical Care Medicine | February 21, 2025 | Volume: 53 | Issue: 3 | Pages: e711-e727

10.1097/ccm.0000000000006574 | PMID 39982143 Get It

RATIONALE: Critically ill adults are at risk for a variety of distressing and consequential symptoms both during and after an ICU stay. Management of these symptoms can directly influence outcomes. OBJECTIVES: The objective was to update and expand the Society of Critical Care Medicine’s 2018 Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. PANEL DESIGN: The interprofessional inclusive guidelines task force was composed of 24 individuals including nurses, physicians, pharmacists, physiotherapists, psychologists, and ICU survivors. The task force developed evidence-based recommendations using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Conflict-of-interest policies were strictly followed in all phases of the guidelines, including task force selection and voting. METHODS: The task force focused on five main content areas as they pertain to adult ICU patients: anxiety (new topic), agitation/sedation, delirium, immobility, and sleep disruption. Using the GRADE approach, we conducted a rigorous systematic review for each population, intervention, control, and outcome question to identify the best available evidence, statistically summarized the evidence, assessed the quality of evidence, and then performed the evidence-to-decision framework to formulate recommendations. RESULTS: The task force issued five statements related to the management of anxiety, agitation/sedation, delirium, immobility, and sleep disruption in adults admitted to the ICU. In adult patients admitted to the ICU, the task force issued conditional recommendations to use dexmedetomidine over propofol for sedation, provide enhanced mobilization/rehabilitation over usual mobilization/rehabilitation, and administer melatonin. The task force was unable to issue recommendations on the administration of benzodiazepines to treat anxiety, and the use of antipsychotics to treat delirium. CONCLUSIONS: The guidelines task force provided recommendations for pharmacologic management of agitation/sedation and sleep, and nonpharmacologic management of immobility in critically ill adults. These recommendations are intended for consideration along with the patient’s clinical status.
Endoscopic ultrasound guided liver biopsy and portal pressure gradient: when, why and how? Can it become the standard of care in endo-hepatology?
Dhar, Jahnvi , Mitra, Suvradeep , Nabi, Zaheer , Aggarwal, Manik , Gupta, Pankaj , Crinò, Stefano Francesco , Trikudanathan, Guru , Crinò, Stefano Francesco , Yadav, Amit, Facciorusso, Antonio , Samanta, Jayanta

Mayo Clinic

Expert Review of Gastroenterology & Hepatology | February 21, 2025 | Volume: 19 | Issue: 3 | Pages: 311-328

10.1080/17474124.2025.2469838 | PMID 39980174 Get It

Medical Education Metaverses (MedEd Metaverses): Opportunities, Use Case, and Guidelines
Mekki, Yosra Magdi , Simon, Leslie V. , Freeman, William D. , Qadir, Junaid , Freeman, William D

Mayo Clinic

Computer | February 20, 2025 | Volume: 58 | Issue: 3 | Pages: 60-70

10.1109/mc.2024.3474033 Get It